Class II
Terminated
Lansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd.
Why: Failed Dissolution Specification
- Company
- Zydus Pharmaceuticals (USA) Inc
Pennington, NJ, United States - Reported
- Nov 11, 2020
- Recall started
- Oct 27, 2020
- Ended
- Dec 20, 2022
- Where sold
- Distributed Nationwide in the USA
- Amount
- 7,908 units
- Full product description
- Lansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-772-77
- Lots / codes affected
- Lot # M005682, EXP 3/2022
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.